Authors:
Petit, B
Leroy, K
Kanavaros, P
Boulland, ML
Druet-Cabanac, M
Haioun, C
Bordessoule, D
Gaulard, P
Citation: B. Petit et al., Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations, HUMAN PATH, 32(2), 2001, pp. 196-204
Authors:
Leroy, K
Dumas, V
Martin-Garcia, N
Falzone, MC
Voisin, MC
Wechsler, J
Revuz, J
Creange, A
Levy, E
Lantieri, L
Zeller, J
Wolkenstein, P
Citation: K. Leroy et al., Malignant peripheral nerve sheath tumors associated with neurofibromatosistype 1 - A clinicopathologic and molecular study of 17 patients, ARCH DERMAT, 137(7), 2001, pp. 908-913
Authors:
Leroy, K
Duyckaerts, C
Bovekamp, L
Muller, O
Anderton, BH
Brion, JP
Citation: K. Leroy et al., Increase of adenomatous polyposis coli immunoreactivity is a marker of reactive astrocytes in Alzheimer's disease and in other pathological conditions, ACT NEUROP, 102(1), 2001, pp. 1-10
Authors:
Leroy, K
Menu, R
Conreur, JL
Dayanandan, R
Lovestone, S
Anderton, BH
Brion, JP
Citation: K. Leroy et al., The function of the microtubule-associated protein tau is variably modulated by graded changes in glycogen synthase kinase-3 beta activity, FEBS LETTER, 465(1), 2000, pp. 34-38
Authors:
McLoughlin, DM
Irving, NG
Brownlees, J
Brion, JP
Leroy, K
Miller, CCJ
Citation: Dm. Mcloughlin et al., Mint2/X11-like colocalizes with the Alzheimer's disease amyloid precursor protein and is associated with neuritic plaques in Alzheimer's disease, EUR J NEURO, 11(6), 1999, pp. 1988-1994
Citation: K. Leroy et Jp. Brion, Developmental expression and localization of glycogen synthase kinase-3 beta in rat brain, J CHEM NEUR, 16(4), 1999, pp. 279-293
Authors:
Dayanandan, R
Van Slegtenhorst, M
Mack, TGA
Ko, L
Yen, SH
Leroy, K
Brion, JP
Anderton, BH
Hutton, M
Lovestone, S
Citation: R. Dayanandan et al., Mutations in tau reduce its microtubule binding properties in intact cellsand affect its phosphorylation, FEBS LETTER, 446(2-3), 1999, pp. 228-232